Royce & Associates’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-69,057	Closed	-$653K	–	1033
2020 Q3	$653K	Buy	69,057 +3,242	+5%	+$35.1K	0.01%	826
2020 Q2	$590K	Hold	65,815	–	–	0.01%	844
2020 Q1	$419K	Hold	65,815	–	–	0.01%	850
2019 Q4	$551K	Hold	65,815	–	–	﹤0.01%	876
2019 Q3	$596K	Hold	65,815	–	–	0.01%	874
2019 Q2	$709K	Hold	65,815	–	–	0.01%	867
2019 Q1	$628K	Sell	65,815 -21,000	-24%	-$214K	0.01%	902
2018 Q4	$997K	Sell	86,815 -54,000	-38%	-$671K	0.01%	863
2018 Q3	$2.39M	Sell	140,815 -115,000	-45%	-$1.75M	0.02%	795
2018 Q2	$3.63M	Buy	255,815 +71,150	+39%	+$1.18M	0.03%	683
2018 Q1	$3.51M	Sell	184,665 -146,300	-44%	-$3.13M	0.02%	676
2017 Q4	$5.43M	Sell	330,965 -147,500	-31%	-$2.19M	0.04%	563
2017 Q3	$7.18M	Sell	478,465 -272,635	-36%	-$3.01M	0.05%	469
2017 Q2	$6.61M	Hold	751,100	–	–	0.04%	501
2017 Q1	$3.91M	Hold	751,100	–	–	0.03%	664
2016 Q4	$2.29M	Buy	751,100 +215,000	+40%	+$783K	0.01%	786
2016 Q3	$2.48M	Buy	536,100 +80,000	+18%	+$407K	0.02%	747
2016 Q2	$2.64M	Hold	456,100	–	–	0.02%	754
2016 Q1	$2.76M	Buy	456,100 +144,000	+46%	+$865K	0.02%	761
2015 Q4	$2.85M	Buy	312,100 +100,000	+47%	+$771K	0.02%	781
2015 Q3	$1.2M	Buy	+212,100	New	+$1.75M	0.01%	946